Form CORRESP - Correspondence:
SEC Accession No. 0001104659-17-037915
Filing Date
2017-06-07
Accepted
2017-06-07 16:00:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 24882
2 GRAPHIC g102912bgi001.jpg GRAPHIC 2730
3 GRAPHIC g102912bgi002.jpg GRAPHIC 2052
  Complete submission text file 0001104659-17-037915.txt   32670
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations